Joseph Pitts said...

FDA approved the first biosimilar in March 2015 and is convening an advisory committee next week to consider a second ap...

This proposal is so far reaching and has caused so much concern it is difficult to imagine any meaningful conclusions ca...

This action by California is a direct violation of the Weldon amendment, which your Department is tasked with enforcing.

I was concerned that CMS finalized its Part B payment policy for biosimilars last year combining all biosimilars into on...